A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis

Completed · Phase 2

Conditions studied: Renal Anemia

In brief

This is a phase II study to evaluate the safety and efficacy of AND017 in renal anemia patients on dialysis

Key facts

Study ID
NCT05265325
Run by
Kind Pharmaceuticals LLC
People needed
175
Starts
2023-05-03
Expected to finish
2024-04-25
Last updated by the study team
2024-06-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.